Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 32

1.

Drug induced exfoliative dermatitis: state of the art.

Yacoub MR, Berti A, Campochiaro C, Tombetti E, Ramirez GA, Nico A, Di Leo E, Fantini P, Sabbadini MG, Nettis E, Colombo G.

Clin Mol Allergy. 2016 Aug 22;14:9. doi: 10.1186/s12948-016-0045-0. Review.

2.

A review of toxic epidermal necrolysis management in Japan.

Kinoshita Y, Saeki H.

Allergol Int. 2017 Jan;66(1):36-41. doi: 10.1016/j.alit.2016.06.001. Review.

3.

Drug reaction with eosinophilia and systemic symptoms (DRESS syndrome).

Silva SA, Figueiredo MM, Carneiro L Neto, Reiss DB, Damásio MA.

Rev Assoc Med Bras (1992). 2016 May-Jun;62(3):227-30. doi: 10.1590/1806-9282.62.03.227. Review.

4.

Long-term valacyclovir treatment and immune modulation for Herpes-associated erythema multiforme.

Staikuniene J, Staneviciute J.

Cent Eur J Immunol. 2015;40(3):387-90. doi: 10.5114/ceji.2015.54604. Review.

5.

[News in severe clinical adverse drug reactions: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN)].

Martínez-Cabriales SA, Gómez-Flores M, Ocampo-Candiani J.

Gac Med Mex. 2015 Nov-Dec;151(6):777-87. Review. Spanish.

6.

Report from the National Institute of Allergy and Infectious Diseases workshop on drug allergy.

Wheatley LM, Plaut M, Schwaninger JM, Banerji A, Castells M, Finkelman FD, Gleich GJ, Guttman-Yassky E, Mallal SA, Naisbitt DJ, Ostrov DA, Phillips EJ, Pichler WJ, Platts-Mills TA, Roujeau JC, Schwartz LB, Trepanier LA.

J Allergy Clin Immunol. 2015 Aug;136(2):262-71.e2. doi: 10.1016/j.jaci.2015.05.027.

7.

New approaches for predicting T cell-mediated drug reactions: A role for inducible and potentially preventable autoimmunity.

Michels AW, Ostrov DA.

J Allergy Clin Immunol. 2015 Aug;136(2):252-7. doi: 10.1016/j.jaci.2015.06.024. Review.

8.

New genetic findings lead the way to a better understanding of fundamental mechanisms of drug hypersensitivity.

Pirmohamed M, Ostrov DA, Park BK.

J Allergy Clin Immunol. 2015 Aug;136(2):236-44. doi: 10.1016/j.jaci.2015.06.022. Review.

9.

Evolving models of the immunopathogenesis of T cell-mediated drug allergy: The role of host, pathogens, and drug response.

White KD, Chung WH, Hung SI, Mallal S, Phillips EJ.

J Allergy Clin Immunol. 2015 Aug;136(2):219-34; quiz 235. doi: 10.1016/j.jaci.2015.05.050. Review.

10.

Toxic epidermal necrolysis.

Hinc-Kasprzyk J, Polak-Krzemińska A, Ożóg-Zabolska I.

Anaesthesiol Intensive Ther. 2015;47(3):257-62. doi: 10.5603/AIT.2015.0037. Review.

11.

Apoptosis in immune-mediated diseases.

Sankari SL, Babu NA, Rajesh E, Kasthuri M.

J Pharm Bioallied Sci. 2015 Apr;7(Suppl 1):S200-2. doi: 10.4103/0975-7406.155902. Review.

12.

[Development of mogamulizumab and establishment of an optimal therapy based on genomic biomarkers: from the academic viewpoint].

Iida S, Ishida T, Ueda R.

Yakugaku Zasshi. 2015;135(5):663-9. doi: 10.1248/yakushi.14-00230-3. Review. Japanese.

13.

Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN): could retinoids play a causative role?

Mawson AR, Eriator I, Karre S.

Med Sci Monit. 2015 Jan 12;21:133-43. doi: 10.12659/MSM.891043. Review.

14.

T cell-mediated hypersensitivity reactions to drugs.

Pavlos R, Mallal S, Ostrov D, Buus S, Metushi I, Peters B, Phillips E.

Annu Rev Med. 2015;66:439-54. doi: 10.1146/annurev-med-050913-022745. Review.

15.

Personalized medicine approaches in epilepsy.

Walker LE, Mirza N, Yip VL, Marson AG, Pirmohamed M.

J Intern Med. 2015 Feb;277(2):218-34. doi: 10.1111/joim.12322. Review.

16.

Bullous lesions in a patient with systemic lupus erythematosus.

Ranario JS, Smith JL.

J Clin Aesthet Dermatol. 2014 Sep;7(9):44-9. Review.

17.

Infliximab/Plasmapheresis in vanishing bile duct syndrome secondary to toxic epidermal necrolysis.

White JC, Appleman S.

Pediatrics. 2014 Oct;134(4):e1194-8. doi: 10.1542/peds.2013-2239. Review.

18.

Adverse drug reactions - examples of detection of rare events using databases.

Chan EW, Liu KQ, Chui CS, Sing CW, Wong LY, Wong IC.

Br J Clin Pharmacol. 2015 Oct;80(4):855-61. doi: 10.1111/bcp.12474. Review.

19.

Histopathology of the nail unit.

Fernandez-Flores A, Saeb-Lima M, Martínez-Nova A.

Rom J Morphol Embryol. 2014;55(2):235-56. Review.

20.

HLA associations and clinical implications in T-cell mediated drug hypersensitivity reactions: an updated review.

Cheng CY, Su SC, Chen CH, Chen WL, Deng ST, Chung WH.

J Immunol Res. 2014;2014:565320. doi: 10.1155/2014/565320. Review.

Supplemental Content

Loading ...
Support Center